Ex-vivo recognition of late-lytic CD8 epitopes specific for Kaposi's sarcoma-associated herpesvirus (KSHV) by HIV/KSHV-coinfected individuals

Viral Immunology

Volumn 24, Issue 3, 2011, Pages 211-220

  Robey, Rebecca C ^a   Mletzko, Salvinia ^a   Bower, Mark ^a   Meys, Rhonda ^a   Boffito, Marta ^a   Nelson, Mark ^a   Bunker, Christopher B ^a   Gotch, Frances M ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; EPITOPE; GAMMA INTERFERON; GLYCOPROTEIN; GLYCOPROTEIN 35; GLYCOPROTEIN 37; GLYCOPROTEIN B; GLYCOPROTEIN H; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; GENE EXPRESSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROPHOBICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIXED INFECTION; OPEN READING FRAME; PHENOTYPE; T LYMPHOCYTE;

ADULT; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SARCOMA, KAPOSI; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79959322994     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2010.0133     Document Type: Article

References (25)

1. Barozzi P, Bonini C, Potenza L, et al.: Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation 2008;86:738-744.
2. Bell MJ, Abbott RJ, Croft NP, Hislop AD, and Burrows SR: An HLA-A2-restricted T-cell epitope mapped to the BNLF2a immune evasion protein of Epstein-Barr virus that inhibits TAP. J Virol 2009;83:2783-2788.
3. Bihl F, Narayan M, Chisholm JV III, et al.: Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes. J Virol 2007;81:4904-4908. (Pubitemid 46668691)
4. Boshoff C, and Weiss R: AIDS-related malignancies. Nat Rev Cancer 2002;2:373-382. (Pubitemid 37328950)
5. Bourboulia D, Aldam D, Lagos D, et al.: Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS 2004;18:485-493. (Pubitemid 38365876)
6. Bower M, Weir J, Francis N, et al.: The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma. AIDS 2009;23:1701-1706.
7. Brander C, O'Connor P, Suscovich T, et al.: Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi's sarcoma-associated herpesvirus kaposin protein. J Infect Dis 2001;184:126.
8. Burrows JM, Wynn KK, Tynan FE, et al.: The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV. Eur J Immunol 2007;37:946-953. (Pubitemid 46925332)
9. Guihot A, Dupin N, Marcelin A-G, et al.: Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. J Infect Dis 2006;194:1078-1088. (Pubitemid 44547647)
10. Guihot A, Oksenhendler E, Galicier L, et al.: Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells. Blood 2008;111:1387-1395. (Pubitemid 351213425)
11. Jenner RG, Alba MM, Boshoff C, and Kellam P: Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 2001;75:891-902. (Pubitemid 32037291)
12. Jenner RG and Boshoff C: The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2002;1602:1-22. (Pubitemid 34311897)
13. Lambert M, Gannage M, Karras A, et al.: Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma. Blood 2006;108:3871-3880. (Pubitemid 44864571)
14. Lautscham G, Mayrhofer S, Taylor G, et al.: Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway. J Exp Med 2001;194:1053-1068. (Pubitemid 32995777)
15. Micheletti F, Monini P, Fortini C, et al.: Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8. Immunology 2002;106:395-403. (Pubitemid 34748134)
16. Parkin DM, Sitas F, Chirenje M, et al.: Part I: Cancer in indigenous Africans - burden, distribution, and trends. Lancet Oncology 2008;9:683-692. (Pubitemid 351878054)-
17. Ribechini E, Fortini C, Marastoni M, et al.: Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8. J Immunol 2006;176:923-930. (Pubitemid 43099690)
18. Robey RC, Lagos D, Gratrix F, et al.: The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens. PLoS ONE 2009;4:e5890.
19. Tian S, Maile R, Collins EJ, and Frelinger JA: CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate. J Immunol 2007;179:2952-2960.
20. Torseth JW, Cohen GH, Eisenberg RJ, et al.: Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses. J Virol 1987;61:1532-1539. (Pubitemid 17069755)
21. Wallace ME, Keating R, Heath WR, and Carbone FR: The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J Virol 1999;73:7619-7626. (Pubitemid 29383246)
22. Wang QJ, Huang XL, Rappocciolo G, et al.: Identification of an HLA A*0201-restricted CD8+ T-cell epitope for the glycoprotein B homolog of human herpesvirus 8. Blood 2002;99:3360-3366. (Pubitemid 34525317)
23. Westrop SJ, Grageda N, and Imami N: Novel approach to recognition of predicted HIV-1 Gag B3501-restricted CD8 T-cell epitopes by HLA-B3501(+) patients: confirmation by quantitative ELISpot analyses and characterisation using multimers. J Immunol Methods 2009;341:76-85.
24. Wilkinson J, Cope A, Gill J, et al.: Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. J Virol 2002;76:2634-2640. (Pubitemid 34184848)
25. Zhu FX, Chong JM, Wu L, and Yuan Y: Virion proteins of Kaposi's sarcoma-associated herpesvirus. J Virol 2005;79:800-811. (Pubitemid 40053863)